Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.380
+0.110 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Titan Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for TTNP.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for TTNP.
Recommendation Trends
| Rating | Dec '21 | Jan '22 | Feb '22 | Mar '22 | Apr '22 | May '22 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 26, 2022 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $220 | Hold → Strong Buy | Upgrades | $220 | +6,408.88% | Feb 18, 2021 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 17, 2020 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $600 | Hold → Strong Buy | Upgrades | $600 | +17,651.48% | Oct 23, 2019 |
| Roth Capital | Roth Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 10, 2017 |
Financial Forecast
Revenue This Year
n/a
from 184.00K
Revenue Next Year
n/a
EPS This Year
n/a
from -7.41
EPS Next Year
n/a
Revenue Forecast
| Revenue |
|---|
| High |
| Avg |
| Low |
Revenue Growth
| Revenue Growth |
|---|
| High |
| Avg |
| Low |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.